Sale!

HAIN Mycobacterium Tuberculosis First and Second Line Drug Resistance Profile Test

Original price was: $196.Current price is: $176.

-10%

The HAIN Mycobacterium Tuberculosis First and Second Line Drug Resistance Profile Test is a cutting-edge molecular diagnostic tool that detects tuberculosis bacteria and identifies resistance to both first-line and second-line anti-TB medications. Using advanced PCR and line probe assay technology, this test provides crucial information about which drugs will be effective against your specific TB strain. This comprehensive resistance profile enables healthcare providers to design personalized treatment regimens, avoiding ineffective medications and reducing treatment duration. The test is particularly valuable for patients with suspected drug-resistant TB, treatment failures, or those from regions with high TB resistance rates. Results are typically available within days, significantly faster than traditional culture methods. At just $176 USD, this test offers exceptional value for optimizing TB treatment outcomes and preventing the spread of drug-resistant strains.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

HAIN Mycobacterium Tuberculosis First and Second Line Drug Resistance Profile Test

Comprehensive TB Drug Resistance Detection

The HAIN Mycobacterium Tuberculosis First and Second Line Drug Resistance Profile Test represents a breakthrough in tuberculosis diagnostics, offering rapid and precise detection of drug-resistant TB strains. This advanced molecular test utilizes cutting-edge PCR and line probe assay technology to identify genetic mutations associated with resistance to multiple anti-tuberculosis medications, providing healthcare providers with critical information for effective treatment planning.

What This Test Measures and Detects

This comprehensive test specifically identifies:

  • Presence of Mycobacterium tuberculosis complex DNA
  • Resistance to first-line TB drugs including isoniazid and rifampicin
  • Resistance to second-line TB medications such as fluoroquinolones and injectable agents
  • Specific genetic mutations associated with drug resistance
  • Multi-drug resistant (MDR-TB) and extensively drug-resistant (XDR-TB) strains

Who Should Consider This Test

This test is particularly recommended for individuals experiencing:

  • Persistent cough lasting more than 3 weeks
  • Unexplained weight loss and fatigue
  • Night sweats and fever
  • Chest pain and breathing difficulties
  • Previous TB treatment failure or relapse
  • Contact with drug-resistant TB patients
  • Immigration from high TB burden countries
  • HIV co-infection or immunocompromised status

Benefits of HAIN TB Drug Resistance Testing

Rapid and Accurate Results

Unlike traditional culture methods that can take weeks, this molecular test provides results within days, enabling prompt initiation of appropriate treatment.

Personalized Treatment Planning

By identifying specific drug resistance patterns, healthcare providers can design targeted treatment regimens, avoiding ineffective medications and reducing side effects.

Prevention of Drug Resistance Spread

Early detection of drug-resistant strains helps prevent transmission to others and contributes to public health efforts to control TB.

Cost-Effective Healthcare

Timely identification of drug resistance prevents prolonged treatment with ineffective drugs, reducing overall healthcare costs and improving patient outcomes.

Understanding Your Test Results

Your test results will provide detailed information about:

  • Sensitive Strains: Medications that are likely to be effective against your TB infection
  • Resistant Strains: Drugs that should be avoided due to genetic resistance markers
  • Resistance Patterns: Comprehensive profile showing first-line and second-line drug susceptibility
  • Treatment Recommendations: Guidance for your healthcare provider on appropriate medication choices

It’s important to discuss your results with your healthcare provider, who will interpret them in the context of your overall health status and develop a personalized treatment plan.

Test Pricing Information

Test Description Price (USD)
HAIN Mycobacterium Tuberculosis First and Second Line Drug Resistance Profile Test – Discount Price $176
HAIN Mycobacterium Tuberculosis First and Second Line Drug Resistance Profile Test – Regular Price $196

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.

Sample Requirements and Processing

Sample Type: Submit 3 mL (2 mL minimum) sputum, bronchoalveolar lavages, bronchial aspirates, or cultured growth on appropriate media in a sterile screw-capped container placed in a sealed plastic bag.

Shipping Instructions: Ship refrigerated. DO NOT FREEZE.

Turnaround Time: Samples submitted by 11 AM Saturday, reports available Friday.

Preparation: No special preparation required.

Take Control of Your TB Treatment Today

Don’t let uncertainty about drug resistance compromise your TB treatment. Our HAIN Mycobacterium Tuberculosis First and Second Line Drug Resistance Profile Test provides the critical information needed for effective, personalized care. With rapid results and comprehensive resistance profiling, you can start the right treatment faster and improve your chances of complete recovery.

Ready to get tested? Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or book online. Our knowledgeable staff is available to answer your questions and help you take the next step toward optimal TB management.